Pfizer submits data to US FDA for 2nd Covid booster in older adults
US drug maker Pfizer has announced that it has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of an additional booster dose for adults 65 years of age and older who have received an initial booster of… Read More »Pfizer submits data to US FDA for 2nd Covid booster in older adults